Onconova Therapeutics
ONTX
$1.00
Share price
-0.47%
Change (1 day)
-11.92%
Change (1 year)
Categories
Operating Margin for Onconova Therapeutics (ONTX)
Operating Margin as of April 2024 (TTM): -8,391.15%
According to Onconova Therapeutics's latest financial reports and stock price the company's current Operating Margin is -8,391.15%. At the end of 2021 the company had an Operating Margin of -7,299.12%.
Operating Margin history for Onconova Therapeutics from 2012 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -7,299.12% | -32.54% |
| 2020 | -10,819.48% | 988.48% |
| 2019 | -994.00% | -47.57% |
| 2018 | -1,895.93% | -42.03% |
| 2017 | -3,270.27% | 665.17% |
| 2016 | -427.39% | 104.25% |
| 2015 | -209.25% | -97.38% |
| 2014 | -7,971.75% | 509.97% |
| 2013 | -1,306.90% | 2733.54% |
| 2012 | -46.12% | -97.39% |
| 2011 | -1,766.98% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Baxter BAX | -19.01% | -99.77% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | -109.76% | -98.69% | 🇺🇸 USA |
 CTI BioPharma
CTIC | -172.37% | -97.95% | 🇺🇸 USA |
 Cleveland BioLabs
CBLI | N/A | N/A | 🇺🇸 USA |
 Array Technologies ARRY | 12.31% | -100.15% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.